Literature DB >> 27133387

Lipoproteins and lipoprotein mimetics for imaging and drug delivery.

C Shad Thaxton1, Jonathan S Rink2, Pratap C Naha3, David P Cormode4.   

Abstract

Lipoproteins are a set of natural nanoparticles whose main role is the transport of fats within the body. While much work has been done to develop synthetic nanocarriers to deliver drugs or contrast media, natural nanoparticles such as lipoproteins represent appealing alternatives. Lipoproteins are biocompatible, biodegradable, non-immunogenic and are naturally targeted to some disease sites. Lipoproteins can be modified to act as contrast agents in many ways, such as by insertion of gold cores to provide contrast for computed tomography. They can be loaded with drugs, nucleic acids, photosensitizers or boron to act as therapeutics. Attachment of ligands can re-route lipoproteins to new targets. These attributes render lipoproteins attractive and versatile delivery vehicles. In this review we will provide background on lipoproteins, then survey their roles as contrast agents, in drug and nucleic acid delivery, as well as in photodynamic therapy and boron neutron capture therapy.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Computed tomography; Drug delivery; Fluorescence imaging; High-density lipoprotein; Low-density lipoprotein; MRI; Photodynamic therapy; siRNA

Mesh:

Substances:

Year:  2016        PMID: 27133387      PMCID: PMC5086317          DOI: 10.1016/j.addr.2016.04.020

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  212 in total

Review 1.  RNAi nanomedicines: challenges and opportunities within the immune system.

Authors:  Shiri Weinstein; Dan Peer
Journal:  Nanotechnology       Date:  2010-05-13       Impact factor: 3.874

2.  Ligand-coupled lipoprotein for ovarian cancer-specific drug delivery.

Authors:  Ian R Corbin
Journal:  Methods Mol Biol       Date:  2013

3.  Binding of high density lipoprotein (HDL) and discoidal reconstituted HDL to the HDL receptor scavenger receptor class B type I. Effect of lipid association and APOA-I mutations on receptor binding.

Authors:  K N Liadaki; T Liu; S Xu; B Y Ishida; P N Duchateaux; J P Krieger; J Kane; M Krieger; V I Zannis
Journal:  J Biol Chem       Date:  2000-07-14       Impact factor: 5.157

4.  Nondenaturing polyacrylamide gradient gel electrophoresis.

Authors:  A V Nichols; R M Krauss; T A Musliner
Journal:  Methods Enzymol       Date:  1986       Impact factor: 1.600

5.  PET Imaging of Tumor-Associated Macrophages with 89Zr-Labeled High-Density Lipoprotein Nanoparticles.

Authors:  Carlos Pérez-Medina; Jun Tang; Dalya Abdel-Atti; Brandon Hogstad; Miriam Merad; Edward A Fisher; Zahi A Fayad; Jason S Lewis; Willem J M Mulder; Thomas Reiner
Journal:  J Nucl Med       Date:  2015-06-25       Impact factor: 10.057

6.  Atherosclerotic plaque composition: analysis with multicolor CT and targeted gold nanoparticles.

Authors:  David P Cormode; Ewald Roessl; Axel Thran; Torjus Skajaa; Ronald E Gordon; Jens-Peter Schlomka; Valentin Fuster; Edward A Fisher; Willem J M Mulder; Roland Proksa; Zahi A Fayad
Journal:  Radiology       Date:  2010-07-28       Impact factor: 11.105

Review 7.  From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I.

Authors:  Morteza Naghavi; Peter Libby; Erling Falk; S Ward Casscells; Silvio Litovsky; John Rumberger; Juan Jose Badimon; Christodoulos Stefanadis; Pedro Moreno; Gerard Pasterkamp; Zahi Fayad; Peter H Stone; Sergio Waxman; Paolo Raggi; Mohammad Madjid; Alireza Zarrabi; Allen Burke; Chun Yuan; Peter J Fitzgerald; David S Siscovick; Chris L de Korte; Masanori Aikawa; K E Juhani Airaksinen; Gerd Assmann; Christoph R Becker; James H Chesebro; Andrew Farb; Zorina S Galis; Chris Jackson; Ik-Kyung Jang; Wolfgang Koenig; Robert A Lodder; Keith March; Jasenka Demirovic; Mohamad Navab; Silvia G Priori; Mark D Rekhter; Raymond Bahr; Scott M Grundy; Roxana Mehran; Antonio Colombo; Eric Boerwinkle; Christie Ballantyne; William Insull; Robert S Schwartz; Robert Vogel; Patrick W Serruys; Goran K Hansson; David P Faxon; Sanjay Kaul; Helmut Drexler; Philip Greenland; James E Muller; Renu Virmani; Paul M Ridker; Douglas P Zipes; Prediman K Shah; James T Willerson
Journal:  Circulation       Date:  2003-10-07       Impact factor: 29.690

8.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

Authors:  J Shepherd; S M Cobbe; I Ford; C G Isles; A R Lorimer; P W MacFarlane; J H McKillop; C J Packard
Journal:  N Engl J Med       Date:  1995-11-16       Impact factor: 91.245

9.  Pre-Clinical Evaluation of rHDL Encapsulated Retinoids for the Treatment of Neuroblastoma.

Authors:  Nirupama Sabnis; Suraj Pratap; Irina Akopova; Paul W Bowman; Andras G Lacko
Journal:  Front Pediatr       Date:  2013-03-21       Impact factor: 3.418

10.  Naphthalocyanine-reconstituted LDL nanoparticles for in vivo cancer imaging and treatment.

Authors:  Liping Song; Hui Li; Ulas Sunar; Juan Chen; Ian Corbin; Arjun G Yodh; Gang Zheng
Journal:  Int J Nanomedicine       Date:  2007
View more
  42 in total

Review 1.  Hybrid lipid-nanoparticle complexes for biomedical applications.

Authors:  Kevin M Vargas; Young-Seok Shon
Journal:  J Mater Chem B       Date:  2019-01-03       Impact factor: 6.331

2.  HDL nanoparticles have wound healing and anti-inflammatory properties and can topically deliver miRNAs.

Authors:  Junyi Wang; Andrea E Calvert; Nihal Kaplan; Kaylin M McMahon; Wending Yang; Kurt Q Lu; Han Peng; C Shad Thaxton; Robert M Lavker
Journal:  Adv Ther (Weinh)       Date:  2020-09-30

3.  Tunable, biodegradable gold nanoparticles as contrast agents for computed tomography and photoacoustic imaging.

Authors:  Rabee Cheheltani; Rami M Ezzibdeh; Peter Chhour; Kumidini Pulaparthi; Johoon Kim; Martina Jurcova; Jessica C Hsu; Cassidy Blundell; Harold I Litt; Victor A Ferrari; Harry R Allcock; Chandra M Sehgal; David P Cormode
Journal:  Biomaterials       Date:  2016-06-07       Impact factor: 12.479

Review 4.  Tolerogenic dendritic cells in organ transplantation.

Authors:  Jordi Ochando; Farideh Ordikhani; Stefan Jordan; Peter Boros; Angus W Thomson
Journal:  Transpl Int       Date:  2019-10-29       Impact factor: 3.782

Review 5.  Phase-Change Materials for Controlled Release and Related Applications.

Authors:  Jichuan Qiu; Da Huo; Younan Xia
Journal:  Adv Mater       Date:  2020-05-08       Impact factor: 30.849

6.  Recent Advances in Molecular Imaging with Gold Nanoparticles.

Authors:  Mathilde Bouché; Jessica C Hsu; Yuxi C Dong; Johoon Kim; Kimberly Taing; David P Cormode
Journal:  Bioconjug Chem       Date:  2019-11-13       Impact factor: 4.774

Review 7.  Nanomedicine Meets microRNA: Current Advances in RNA-Based Nanotherapies for Atherosclerosis.

Authors:  Suresh Gadde; Katey J Rayner
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-09       Impact factor: 8.311

8.  Core hydrophobicity tuning of a self-assembled particle results in efficient lipid reduction and favorable organ distribution.

Authors:  Bhabatosh Banik; Ru Wen; Sean Marrache; Anil Kumar; Nagesh Kolishetti; Elizabeth W Howerth; Shanta Dhar
Journal:  Nanoscale       Date:  2017-12-21       Impact factor: 7.790

Review 9.  Functional role of extracellular vesicles and lipoproteins in the tumour microenvironment.

Authors:  Julien A Menard; Myriam Cerezo-Magaña; Mattias Belting
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-01-05       Impact factor: 6.237

Review 10.  Biomimetics: reconstitution of low-density lipoprotein for targeted drug delivery and related theranostic applications.

Authors:  Chunlei Zhu; Younan Xia
Journal:  Chem Soc Rev       Date:  2017-12-11       Impact factor: 54.564

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.